Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Mayne Pharma Group ( (AU:MYX) ) is now available.
Mayne Pharma Group Limited has requested a trading halt on its securities pending a significant announcement regarding a proposed acquisition by Cosette through a scheme of arrangement. This move indicates a strategic shift that could impact the company’s market positioning and stakeholder interests, as the trading halt will remain until the announcement is made or normal trading resumes.
The most recent analyst rating on (AU:MYX) stock is a Buy with a A$7.09 price target. To see the full list of analyst forecasts on Mayne Pharma Group stock, see the AU:MYX Stock Forecast page.
More about Mayne Pharma Group
Mayne Pharma Group Limited is a pharmaceutical company that specializes in the development and manufacturing of branded and generic pharmaceutical products. The company focuses on providing innovative solutions in the healthcare industry, catering to a diverse market with a range of therapeutic offerings.
YTD Price Performance: 30.38%
Average Trading Volume: 904,112
Technical Sentiment Signal: Buy
Current Market Cap: A$526.5M
Find detailed analytics on MYX stock on TipRanks’ Stock Analysis page.